FI81350C - Analogfoerfarande foer framstaellning av nya, farmakologiskt aktiva 6-substituerade s-triatsolo/3,4-a/ ftalazinderivat. - Google Patents
Analogfoerfarande foer framstaellning av nya, farmakologiskt aktiva 6-substituerade s-triatsolo/3,4-a/ ftalazinderivat. Download PDFInfo
- Publication number
- FI81350C FI81350C FI830100A FI830100A FI81350C FI 81350 C FI81350 C FI 81350C FI 830100 A FI830100 A FI 830100A FI 830100 A FI830100 A FI 830100A FI 81350 C FI81350 C FI 81350C
- Authority
- FI
- Finland
- Prior art keywords
- formula
- group
- triazolo
- phthalazine
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8201273 | 1982-01-18 | ||
GB8201273 | 1982-01-18 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI830100A0 FI830100A0 (fi) | 1983-01-12 |
FI830100L FI830100L (fi) | 1983-07-19 |
FI81350B FI81350B (fi) | 1990-06-29 |
FI81350C true FI81350C (fi) | 1990-10-10 |
Family
ID=10527683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI830100A FI81350C (fi) | 1982-01-18 | 1983-01-12 | Analogfoerfarande foer framstaellning av nya, farmakologiskt aktiva 6-substituerade s-triatsolo/3,4-a/ ftalazinderivat. |
Country Status (20)
Country | Link |
---|---|
US (1) | US4788186A (hu) |
EP (1) | EP0085840B1 (hu) |
JP (1) | JPS58124786A (hu) |
KR (1) | KR890000184B1 (hu) |
AT (1) | ATE22562T1 (hu) |
AU (1) | AU564026B2 (hu) |
CA (1) | CA1214168A (hu) |
DE (1) | DE3366494D1 (hu) |
DK (1) | DK163145C (hu) |
ES (1) | ES531458A0 (hu) |
FI (1) | FI81350C (hu) |
GR (1) | GR78442B (hu) |
HU (1) | HU193033B (hu) |
IE (1) | IE55032B1 (hu) |
IL (1) | IL67697A (hu) |
NO (1) | NO161674C (hu) |
NZ (1) | NZ203021A (hu) |
PH (1) | PH21834A (hu) |
PT (1) | PT76107A (hu) |
ZA (1) | ZA83224B (hu) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1194310B (it) * | 1983-07-12 | 1988-09-14 | Lepetit Spa | Derivati triazolo (3,4-a) ftalazinici 3,6-disostituiti |
NZ333768A (en) * | 1996-07-25 | 2000-09-29 | Merck Sharp & Dohme | Substituted triazolo-pyridazine derivatives as ligands for GABA receptors |
AU724076B2 (en) | 1996-07-25 | 2000-09-14 | Merck Sharp & Dohme Limited | Substituted triazolo pyridazine derivatives as inverse agonists of the GABAAalpha5 receptor subtype |
EP0986562B1 (en) | 1997-05-08 | 2002-08-07 | MERCK SHARP & DOHME LTD. | Substituted 1,2,4-triazolo 3,4-a]phthalazine derivatives as gaba alpha 5 ligands |
GB9715977D0 (en) | 1997-07-29 | 1997-10-01 | Merck Sharp & Dohme | Therapeutic agents |
ES2137113B1 (es) * | 1997-07-29 | 2000-09-16 | Almirall Prodesfarma Sa | Nuevos derivados de triazolo-piridazinas heterociclicos. |
GB9726701D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
GB9726699D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
WO1999025353A1 (en) * | 1997-11-13 | 1999-05-27 | Merck Sharp & Dohme Limited | Therapeutic uses of triazolo-pyridazine derivatives |
GB9723999D0 (en) | 1997-11-13 | 1998-01-14 | Merck Sharp & Dohme | Therapeutic use |
GB9726702D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
US6110915A (en) * | 1997-12-18 | 2000-08-29 | Merck & Co., Inc. | Antiemetic use of triazolo-pyridazine derivatives |
WO1999036423A1 (en) * | 1998-01-14 | 1999-07-22 | Merck Sharp & Dohme Limited | Triazolo-pyridazine derivatives as ligands for gaba receptors |
GEP20032868B (en) * | 1998-01-21 | 2003-01-27 | Merck Sharp & Dohme | Triazolo-Pyridazine Derivatives as Ligands for Gaba Receptors, Methods for Their Production, Pharmaceutical Compositions Containing the Same for Treatment and/or Prevention of disorders of Central Nervous System |
GB9801210D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
GB9801208D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
GB9801234D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
GB9801202D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
GB9801397D0 (en) * | 1998-01-22 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
GB9801538D0 (en) | 1998-01-23 | 1998-03-25 | Merck Sharp & Dohme | Pharmaceutical product |
AU746719B2 (en) * | 1998-02-25 | 2002-05-02 | Merck Sharp & Dohme Limited | Substituted 1,2,4-triazolo(3,4-a)pyridazine |
YU46500A (sh) | 1998-02-25 | 2002-11-15 | Merck Charp & Dohme Limited | Substituisani 1,2,4-triazolo /3,4-a/piridazin |
GB9824897D0 (en) | 1998-11-12 | 1999-01-06 | Merck Sharp & Dohme | Therapeutic compounds |
EP1129094A2 (en) | 1998-11-12 | 2001-09-05 | Merck & Co., Inc. | Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
GB9929569D0 (en) * | 1999-12-14 | 2000-02-09 | Merck Sharp & Dohme | Therapeutic agents |
GB0028583D0 (en) | 2000-11-23 | 2001-01-10 | Merck Sharp & Dohme | Therapeutic compounds |
WO2002083064A2 (en) * | 2001-04-10 | 2002-10-24 | Merck & Co., Inc. | A method of treating cancer |
US6958334B2 (en) * | 2001-04-10 | 2005-10-25 | Merck & Co., Inc. | Inhibitors of Akt activity |
EP1496981A2 (en) * | 2002-04-08 | 2005-01-19 | Merck & Co., Inc. | Method of treating cancer |
US20050054647A1 (en) * | 2002-12-27 | 2005-03-10 | Detlev Schuppan | New pharmaceutical combination |
KR101368093B1 (ko) | 2004-09-02 | 2014-03-14 | 다케다 게엠베하 | 트리아졸로프탈라진 |
AU2006204451C1 (en) * | 2005-01-05 | 2012-05-24 | Takeda Gmbh | Triazolophthalazines as PDE2-inhibitors |
EA012505B1 (ru) * | 2005-01-05 | 2009-10-30 | Никомед Гмбх | Триазолофталазины в качестве ингибиторов pde-2 |
SG182297A1 (en) | 2009-12-31 | 2012-08-30 | Ct Nac Investigaciones Oncologicas Cnio | Tricyclic compounds for use as kinase inhibitors |
CN103694244B (zh) * | 2014-01-09 | 2016-03-30 | 郑州大学 | 3,6位取代-1,2,4-三氮唑并[3,4-a]酞嗪类化合物及其制备和用途 |
CN104016986B (zh) * | 2014-03-13 | 2016-02-03 | 郑州大学 | 3-取代-6-(1-取代哌嗪基)-1,2,4-三氮唑并[3,4-a]酞嗪类化合物、其制备方法和用途 |
EP4279074A1 (en) * | 2022-05-19 | 2023-11-22 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | Azolo compounds for treatment of fibrotic diseases |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2484029A (en) * | 1945-12-21 | 1949-10-11 | Ciba Pharm Prod Inc | Hydrazine derivatives of pyridazine compounds |
GB629177A (en) * | 1945-12-21 | 1949-09-14 | Ciba Ltd | Manufacture of new hydrazine compounds and derivatives thereof |
JPS5132598A (en) * | 1974-09-13 | 1976-03-19 | Eisai Co Ltd | Toriazoro * 3 44 ee * futarajinjudotai no goseiho |
JPS603080B2 (ja) * | 1976-08-10 | 1985-01-25 | 三菱化学株式会社 | S―トリアゾロ〔3,4 ―α〕〔5,6,7,8〕テトラヒドロ フタラジン類 |
GR70309B (hu) * | 1979-10-29 | 1982-09-08 | Dow Chemical Co |
-
1983
- 1983-01-12 FI FI830100A patent/FI81350C/fi not_active IP Right Cessation
- 1983-01-12 PH PH28380A patent/PH21834A/en unknown
- 1983-01-13 ZA ZA83224A patent/ZA83224B/xx unknown
- 1983-01-13 AT AT83100232T patent/ATE22562T1/de not_active IP Right Cessation
- 1983-01-13 GR GR70257A patent/GR78442B/el unknown
- 1983-01-13 EP EP83100232A patent/EP0085840B1/en not_active Expired
- 1983-01-13 DE DE8383100232T patent/DE3366494D1/de not_active Expired
- 1983-01-13 CA CA000419398A patent/CA1214168A/en not_active Expired
- 1983-01-13 NZ NZ203021A patent/NZ203021A/en unknown
- 1983-01-14 NO NO830110A patent/NO161674C/no unknown
- 1983-01-17 HU HU83141A patent/HU193033B/hu not_active IP Right Cessation
- 1983-01-17 IL IL67697A patent/IL67697A/xx unknown
- 1983-01-17 IE IE82/83A patent/IE55032B1/en not_active IP Right Cessation
- 1983-01-18 JP JP58005413A patent/JPS58124786A/ja active Granted
- 1983-01-18 AU AU10550/83A patent/AU564026B2/en not_active Ceased
- 1983-01-18 DK DK017983A patent/DK163145C/da not_active IP Right Cessation
- 1983-01-18 KR KR1019830000174A patent/KR890000184B1/ko not_active IP Right Cessation
- 1983-01-18 PT PT76107A patent/PT76107A/pt unknown
-
1984
- 1984-04-10 ES ES531458A patent/ES531458A0/es active Granted
-
1987
- 1987-10-20 US US07/112,015 patent/US4788186A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PH21834A (en) | 1988-03-17 |
DK17983D0 (da) | 1983-01-18 |
ES8601995A1 (es) | 1985-11-01 |
IE830082L (en) | 1983-07-18 |
JPH048428B2 (hu) | 1992-02-17 |
KR840003254A (ko) | 1984-08-20 |
FI830100L (fi) | 1983-07-19 |
JPS58124786A (ja) | 1983-07-25 |
KR890000184B1 (ko) | 1989-03-09 |
DK17983A (da) | 1983-07-19 |
ATE22562T1 (de) | 1986-10-15 |
AU1055083A (en) | 1983-07-28 |
FI81350B (fi) | 1990-06-29 |
US4788186A (en) | 1988-11-29 |
DE3366494D1 (de) | 1986-11-06 |
AU564026B2 (en) | 1987-07-30 |
NO830110L (no) | 1983-07-19 |
NZ203021A (en) | 1986-05-09 |
ES531458A0 (es) | 1985-11-01 |
HU193033B (en) | 1987-08-28 |
IL67697A0 (en) | 1983-05-15 |
CA1214168A (en) | 1986-11-18 |
DK163145C (da) | 1992-06-22 |
NO161674C (no) | 1989-09-13 |
GR78442B (hu) | 1984-09-27 |
ZA83224B (en) | 1983-10-26 |
EP0085840A1 (en) | 1983-08-17 |
PT76107A (en) | 1983-02-01 |
FI830100A0 (fi) | 1983-01-12 |
EP0085840B1 (en) | 1986-10-01 |
IE55032B1 (en) | 1990-05-09 |
IL67697A (en) | 1990-02-09 |
DK163145B (da) | 1992-01-27 |
NO161674B (no) | 1989-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI81350C (fi) | Analogfoerfarande foer framstaellning av nya, farmakologiskt aktiva 6-substituerade s-triatsolo/3,4-a/ ftalazinderivat. | |
CN105555784B (zh) | 作为组蛋白去甲基化酶抑制剂的被取代的(e)-n’-(1-苯亚乙基)苯甲酰肼类似物 | |
CN105209463B (zh) | 2‑氨基吡啶并[4,3‑d]嘧啶‑5‑酮衍生物及其作为Wee‑1抑制剂的用途 | |
EP0134946B1 (en) | 3,6-Disubstituted-triazolo[3,4-a]phthalazine derivatives | |
US20060189631A1 (en) | Substituted imidazopyrimidines for the prevention and treatment of cancer | |
CA2706018A1 (en) | 1, 5-dihydro-pyrazolo [3,4-d]pyrimidin-4-one derivatives and their use as pde9a modulators for the treatment of cns disorders | |
KR20110017845A (ko) | Mtor 억제자 염 형태 | |
EA004373B1 (ru) | 1-АМИНОТРИАЗОЛО[4,3-a]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ IV | |
BR112012029919B1 (pt) | PROCESSO PARA PREPARAÇÃO DE 8-ALCÓXI [1,2,4] TRIAZOLO[1,5-c]PIRIMIDIN-2-AMINAS, SUBSTITUÍDAS NA POSIÇÃO 5, E SEUS INTERMEDIÁRIOS | |
JP2011530574A (ja) | 2−アルキル−6−シクロアミノ−3−(ピリジン−4−イル)イミダゾ[1,2−ib]ピリダジン誘導体、この調製およびこの治療応用 | |
Okuda et al. | Polycyclic N‐Heterocyclic Compounds. Part 86: Synthesis and Evaluation of Antiplatelet Aggregation Activity of 2, 4‐Disubstituted 9‐Chloro‐5, 6‐dihydropyrimido [5, 4‐d] benzazepine and Related Compounds | |
TWI472530B (zh) | 蛋白質激酶抑制劑 | |
EP3397640A1 (en) | Xanthine derivative inhibitors of bet proteins | |
WO1997023456A1 (en) | Indoloquinone derivatives as bioreductive agents | |
CA2483496A1 (en) | Inhibitors of checkpoint kinases (wee1 and chk1) | |
SG176169A1 (en) | Anticancer compound and pharmaceutical composition containing the same | |
Cecchetti et al. | Quinolinecarboxylic acids. 3. Synthesis and antibacterial evaluation of 2-substituted 7-oxo-2, 3-dihydro-7H-pyrido [1, 2, 3-de][1, 4] benzothiazine-6-carboxylic acids related to rufloxacin | |
WO2000047582A1 (en) | Triazolo-pyridazine derivatives as ligands for gaba receptors | |
Birch et al. | Syntheses of flosequinan: a novel 4-quinolone shown to be useful in congestive heart failure | |
Riedl et al. | Synthesis of novel 1-methyl-1H-pyridazino [3, 4-b] indoles | |
US4547501A (en) | Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents | |
Barlin et al. | Imidazo [1, 2-b] Pyridazines. XVI. Synthesis and Central Nervous System Activities of Some 6-(Chloro, Alkylthio, Phenylthio, Benzylthio or Pyridinylmethylthio)-3-(unsubstituted, benzamidomethyl or methoxy)-2-(styryl or benzoyl) imidazo [1, 2-b] pyridazines | |
Rosen et al. | Discovery of potent cholecystokinin-2 receptor antagonists: Elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysis | |
Uff et al. | Studies concerning pyrrolo [2, 1‐a] phthalazines and related compounds | |
Jakubkiene et al. | Synthesis and Functionalization of 8‐Methyl‐2h‐pyrimido [2, 1‐c][1, 2, 4] triazine‐3, 6 (1h, 4h)‐dione |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: GRUPPO LEPETIT S.P.A. |